PSNL Personalis, Inc.

NEUTRAL Impact: 3/10 144
Horizon days Filed May 29, 2026 Processed 16d 15h ago SEC 0001950047-26-005302
Form 144 — notice of proposed sale of securities
Latest settled — T+5d ⚠ clustered
PSNL ▼ -4.53% at T+5d
NEUTRAL call ✗ call lost -4.53% · α vs SPY -1.78% · entry $11.26 → $10.75
Next anchor: T+20d in 14d
Last close $9.59 (close Jun 12) · -14.83% from $11.26 entry
Entry anchored
May 29, 2026
via day open
T+1d
-1.07%
call -1.07% · α -1.21%
$11.14
settled 14d ago
T+5d
-4.53%
call -4.53% · α -1.78%
$10.75
settled 10d ago
T+20d
call — · α —
in 14d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Aaron Tachibana, an officer of Personalis, Inc., filed a Form 144 on May 29, 2026, indicating intent to sell 38,799 shares of common stock, with an estimated aggregate market value of approximately $426,013. The shares are proposed to be sold following the exercise of stock options. This is a routine insider transaction for tax or diversification purposes, but the timing and size relative to the officer's holdings are not disclosed in the filing.

Actionable Insight

This is a routine insider sale following option exercise, likely for tax or liquidity purposes. The small size relative to market cap suggests no material signal. Monitor for any subsequent Form 4 filings to confirm execution, and watch for any unusual insider selling patterns ahead of the next earnings report.

Key Facts

  • Officer Aaron Tachibana filed Form 144 to sell 38,799 shares of Personalis common stock.
  • Estimated aggregate market value of the proposed sale is approximately $426,013.
  • Shares were acquired through the exercise of stock options on May 29, 2026.
  • The sale is proposed to occur on or after May 29, 2026, on the Nasdaq exchange.
  • No other insider sales or purchases were reported in the prior 30 days.

Financial Impact

Proposed sale of 38,799 shares valued at ~$426,013, representing a small fraction of the company's $1.1B market cap.

dilution

Risk Factors

  • Insider sale could signal lack of confidence if followed by additional large sales by other officers.
  • Form 144 is only an intent to sell; the sale may not occur.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
85% bullish (13 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-005302
Document: 0001950047-26-005302-index.html0001950047-26-005302
Document: 0001950047-26-005302.txt0001950047-26-005302
5 reports for PSNL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for PSNL — sortable, filterable
Type Now
Jun 6, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
$11.75 awaiting T+5awaiting T+5$9.59 (−18.38%)
Jun 4, 2026
10d ago
144
NEUTRAL ★ 3/10
$12.08 awaiting T+5awaiting T+5$9.59 (−20.61%)
May 30, 2026
16d ago
Insider Cluster
BEARISH ★ 5/10
$11.26 $10.75▲ +4.53%▲ +1.78%$9.59 (+14.83%)
May 29, 2026
16d ago
144
NEUTRAL ★ 3/10
$11.26 $10.75▼ −4.53%▼ −1.78%$9.59 (−14.83%)
May 28, 2026
17d ago
144
BEARISH ★ 5/10
$11.40 $10.75▲ +5.70%▲ +3.18%$9.59 (+15.88%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 1h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access